Generic Drug Product Development: Solid Oral Dosage Forms
"This book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulations, pharmaceutical ingredients, conventional and modified-release products, and bioequivalence. It considers key elements in the formulation of generic drug pro...
Shranjeno v:
| Drugi avtorji: | , |
|---|---|
| Format: | Knjiga |
| Jezik: | angleščina |
| Izdano: |
New York
CRC Press is an Imprint of Taylor & Francis Group
2020
|
| Izdaja: | 2nd ed. |
| Serija: | Drugs and The Pharmaceutical Sciences Series
Vol - 212 |
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
MARC
| LEADER | 00000nam a22000007a 4500 | ||
|---|---|---|---|
| 008 | 211007b ||||| |||| 00| 0 eng d | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 615_190000000000000_SHA |7 0 |9 12320 |a 50008178 |b 50008178 |d 2021-03-30 |e Pharma Book Syndicate Hyderabad |g 3995.00 |l 0 |o 615.19 SHA |p JP001599 |r 2021-10-07 00:00:00 |w 2021-10-07 |y RB | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 615_190000000000000_SHA |7 0 |9 17674 |a 50008178 |b 50008178 |d 2024-10-24 |e Ao Enterprises |g 3056.60 |l 0 |o 615.19 SHA |p JP002051 |r 2024-10-24 12:24:41 |v 4495.00 |w 2024-10-24 |y RB | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 615_190000000000000_SHA |7 0 |9 17675 |a 50008178 |b 50008178 |d 2024-10-24 |e Ao Enterprises |g 3056.60 |l 0 |o 615.19 SHA |p JP002052 |r 2024-10-24 12:24:41 |v 4495.00 |w 2024-10-24 |y RB | ||
| 999 | |c 6896 |d 6896 | ||
| 020 | |a 9780367894894 | ||
| 082 | |a 615.19 |b GEN | ||
| 245 | |a Generic Drug Product Development: Solid Oral Dosage Forms | ||
| 250 | |a 2nd ed. | ||
| 260 | |a New York |b CRC Press is an Imprint of Taylor & Francis Group |c 2020 | ||
| 300 | |a xii, 385 p. | ||
| 490 | |a Drugs and The Pharmaceutical Sciences Series |v Vol - 212 | ||
| 520 | |a "This book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulations, pharmaceutical ingredients, conventional and modified-release products, and bioequivalence. It considers key elements in the formulation of generic drug products including the availability of raw materials and chemical purity. It contains new chapters on experimental formulation development, and the relationship between the FDA and the United States Pharmacopeia" | ||
| 650 | |a Generic Drugs |9 8287 | ||
| 650 | |a Solid Dosage Forms |9 8288 | ||
| 650 | |a Drugs, Generic - Standards |9 8272 | ||
| 700 | |a Shargel, Leon |9 8289 | ||
| 700 | |a Kanfer, Isadore |9 8290 | ||